1OQA
| Solution structure of the BRCT-c domain from human BRCA1 | Descriptor: | Breast cancer type 1 susceptibility protein | Authors: | Gaiser, O.J, Ball, L.J, Schmieder, P, Leitner, D, Strauss, H, Wahl, M, Kuhne, R, Oschkinat, H, Heinemann, U. | Deposit date: | 2003-03-07 | Release date: | 2004-06-15 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1. Biochemistry, 43, 2004
|
|
1Q8X
| NMR structure of human cofilin | Descriptor: | Cofilin, non-muscle isoform | Authors: | Pope, B.J, Zierler-Gould, K.M, Kuhne, R, Weeds, A.G, Ball, L.J. | Deposit date: | 2003-08-22 | Release date: | 2004-07-06 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | The solution structure of human cofilin: rationalizing actin binding and pH sensitivity J.Biol.Chem., 279, 2004
|
|
1Z57
| Crystal structure of human CLK1 in complex with 10Z-Hymenialdisine | Descriptor: | DEBROMOHYMENIALDISINE, Dual specificity protein kinase CLK1 | Authors: | Debreczeni, J, Das, S, Knapp, S, Bullock, A, Guo, K, Amos, A, Fedorov, O, Edwards, A, Sundstrom, M, von Delft, F, Niesen, F.H, Ball, L, Sobott, F, Arrowsmith, C, Structural Genomics Consortium (SGC) | Deposit date: | 2005-03-17 | Release date: | 2005-04-12 | Last modified: | 2023-08-23 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation. Structure, 17, 2009
|
|
2AHS
| Crystal Structure of the Catalytic Domain of Human Tyrosine Receptor Phosphatase Beta | Descriptor: | 1,2-ETHANEDIOL, CHLORIDE ION, Receptor-type tyrosine-protein phosphatase beta, ... | Authors: | Ugochukwu, E, Eswaran, J, Barr, A, Gileadi, O, Sobott, F, Burgess, N, Ball, L, Bray, J, von Delft, F, Debreczeni, J, Bunkoczi, G, Turnbull, A, Das, S, Weigelt, J, Edwards, A, Arrowsmith, C, Sundstrom, M, Knapp, S, Structural Genomics Consortium (SGC) | Deposit date: | 2005-07-28 | Release date: | 2005-08-09 | Last modified: | 2023-08-23 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell(Cambridge,Mass.), 136, 2009
|
|
6RMO
| Structure of Plasmodium falciparum IMP-nucleotidase | Descriptor: | IMP-specific 5'-nucleotidase, putative | Authors: | Carrique, L, Ballut, L, Violot, S, Aghajari, N. | Deposit date: | 2019-05-07 | Release date: | 2020-07-15 | Last modified: | 2024-01-24 | Method: | X-RAY DIFFRACTION (2.6 Å) | Cite: | Structure and catalytic regulation of Plasmodium falciparum IMP specific nucleotidase. Nat Commun, 11, 2020
|
|
6RNH
| Structure of C-terminal truncated Plasmodium falciparum IMP-nucleotidase | Descriptor: | GLYCEROL, IMP-specific 5'-nucleotidase, putative | Authors: | Carrique, L, Ballut, L, Violot, S, Aghajari, N. | Deposit date: | 2019-05-08 | Release date: | 2020-07-15 | Last modified: | 2024-01-24 | Method: | X-RAY DIFFRACTION (3.7 Å) | Cite: | Structure and catalytic regulation of Plasmodium falciparum IMP specific nucleotidase. Nat Commun, 11, 2020
|
|
6RN1
| Structure of N-terminal truncated Plasmodium falciparum IMP-nucleotidase | Descriptor: | IMP-specific 5'-nucleotidase, putative | Authors: | Carrique, L, Ballut, L, Violot, S, Aghajari, N. | Deposit date: | 2019-05-07 | Release date: | 2020-07-15 | Last modified: | 2024-01-24 | Method: | X-RAY DIFFRACTION (3 Å) | Cite: | Structure and catalytic regulation of Plasmodium falciparum IMP specific nucleotidase. Nat Commun, 11, 2020
|
|
6RMW
| Structure of N-terminal truncated IMP bound Plasmodium falciparum IMP-nucleotidase | Descriptor: | GLYCEROL, IMP-specific 5'-nucleotidase, putative, ... | Authors: | Carrique, L, Ballut, L, Violot, S, Aghajari, N. | Deposit date: | 2019-05-07 | Release date: | 2020-07-15 | Last modified: | 2024-01-24 | Method: | X-RAY DIFFRACTION (3.5 Å) | Cite: | Structure and catalytic regulation of Plasmodium falciparum IMP specific nucleotidase. Nat Commun, 11, 2020
|
|
6RME
| Structure of IMP bound Plasmodium falciparum IMP-nucleotidase mutant D172N | Descriptor: | GLYCEROL, IMP-specific 5'-nucleotidase, putative, ... | Authors: | Carrique, L, Ballut, L, Violot, S, Aghajari, N. | Deposit date: | 2019-05-06 | Release date: | 2020-07-08 | Last modified: | 2024-01-24 | Method: | X-RAY DIFFRACTION (3.4 Å) | Cite: | Structure and catalytic regulation of Plasmodium falciparum IMP specific nucleotidase. Nat Commun, 11, 2020
|
|
7QP1
| Crystal structure of metacaspase from candida glabrata with calcium | Descriptor: | CALCIUM ION, CHLORIDE ION, Metacaspase-1 | Authors: | Conchou, L, Ballut, L, Violot, S, Aghajari, N. | Deposit date: | 2021-12-30 | Release date: | 2023-01-11 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (3 Å) | Cite: | Structural and molecular determinants of Candida glabrata metacaspase maturation and activation by calcium. Commun Biol, 5, 2022
|
|
6RMD
| Structure of ATP bound Plasmodium falciparum IMP-nucleotidase | Descriptor: | 1,2-ETHANEDIOL, ADENOSINE-5'-TRIPHOSPHATE, IMP-specific 5'-nucleotidase, ... | Authors: | Carrique, L, Ballut, L, Violot, S, Aghajari, N. | Deposit date: | 2019-05-06 | Release date: | 2020-07-15 | Last modified: | 2024-05-15 | Method: | X-RAY DIFFRACTION (2.8 Å) | Cite: | Structure and catalytic regulation of Plasmodium falciparum IMP specific nucleotidase. Nat Commun, 11, 2020
|
|
7QP0
| Crystal structure of metacaspase from candida glabrata with magnesium | Descriptor: | 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, MAGNESIUM ION, Metacaspase-1 | Authors: | Conchou, L, Ballut, L, Violot, S, Aghajari, N. | Deposit date: | 2021-12-30 | Release date: | 2023-01-11 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.6 Å) | Cite: | Structural and molecular determinants of Candida glabrata metacaspase maturation and activation by calcium. Commun Biol, 5, 2022
|
|
2XNI
| Protein-ligand complex of a novel macrocyclic HCV NS3 protease inhibitor derived from amino cyclic boronates | Descriptor: | (1-{[(10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19,23,23a-tetradecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosin-7(3H)-yl)carbonyl]amino}-3-hydroxypropyl)(trihydroxy)borate(1-), MAGNESIUM ION, NS3 PROTEASE, ... | Authors: | Li, X, Zhang, Y.-K, Liu, Y, Ding, C.Z, Zhou, Y, Li, Q, Plattner, J.J, Baker, S.J, Zhang, S, Kazmierski, W.M, Wright, L.L, Smith, G.K, Grimes, R.M, Crosby, R.M, Creech, K.L, Carballo, L.H, Slater, M.J, Jarvest, R.L, Thommes, P, Hubbard, J.A, Convery, M.A, Nassau, P.M, McDowell, W, Skarzynski, T.J, Qian, X, Fan, D, Liao, L, Ni, Z.-J, Pennicott, L.E, Zou, W, Wright, J. | Deposit date: | 2010-08-02 | Release date: | 2011-08-17 | Last modified: | 2012-09-26 | Method: | X-RAY DIFFRACTION (3.3 Å) | Cite: | Novel Macrocyclic Hcv Ns3 Protease Inhibitors Derived from Alpha-Amino Cyclic Boronates. Bioorg.Med.Chem.Lett., 20, 2010
|
|